Literature DB >> 9400894

Guidelines for the treatment of acute exacerbations of chronic bronchitis.

R F Grossman1.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9400894     DOI: 10.1378/chest.112.6_supplement.310s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  12 in total

1.  Acute renal failure probably induced by prulifloxacin in an elderly woman : a first case report.

Authors:  L Gallelli; A Gallelli; G Vero; F Roccia; G Pelaia; G De Sarro; R Maselli
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

2.  Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.

Authors:  Sanjay Sethi; John Breton; Brian Wynne
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practice.

Authors:  T Schaberg; M Möller; T File; K Stauch; H Landen
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

4.  Drug use evaluation of moxifloxacin (avelox) using a hand-held electronic device at a canadian teaching hospital.

Authors:  Jennifer A E Samilski; Tim T Y Lau; Dean H T Elbe; Amneet K Aulakh; Eric M C Lun
Journal:  P T       Date:  2012-05

5.  Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.

Authors:  Jose-Luis Alvarez-Sala; Peter Kardos; Jesús Martínez-Beltrán; Pilar Coronel; Lorenzo Aguilar
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

Review 6.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Prulifloxacin.

Authors:  Susan J Keam; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management.

Authors:  Don Hayes; Keith C Meyer
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 9.  Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient.

Authors:  Timothy F Murphy; Sanjay Sethi
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  Optimizing economic outcomes in acute exacerbations of chronic bronchitis.

Authors:  Christopher J Destache
Journal:  Pharmacotherapy       Date:  2002-01       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.